Retinal Microperimetry As a Novel Tool for Early Detection of Subclinical Cognitive Dysfunction and Brain Damage in Type 1 Diabetes: A Pilot Study

Overview

Journal Endocrinol Diabetes Metab

Specialty Endocrinology

Date 2024 Dec 21

PMID 39707866

Authors

Manel Mateu-Salat

Nicole Stanton-Yonge

Frederic Sampedro Santalo

Jose Ignacio Vela

Jesus Diaz Cascajosa

Eva Safont Perez

Daniela Rego-Lorca

Ana Chico

Affiliations

Soon will be listed here.

Abstract

Context: Retinal microperimetry (MPR) is a non-invasive method that measures retinal light sensitivity (RS) and gaze fixation stability (GFS). MPR has been described as a marker of cognitive impairment in people with Type 2 diabetes, but it has never been assessed in people with Type 1 diabetes (T1D). Our group described subclinical cognitive alterations, structural brain differences, and increased levels of light chain neurofilament (NfL) in people with T1D and impaired awareness of hypoglycaemia.

Objective: To measure RS and GFS using MPR in individuals with T1D and evaluate its correlation with neuropsychological assessment, plasma NfL levels and CGM-derived glucometric parameters.

Secondary Objectives: to evaluate the possible differences of RS and GFS in people with T1D depending on hypoglycaemia awareness.

Design, Setting And Participants: Pilot observational study, people with T1D without clinical cognitive impairment, moderate-severe retinopathy or glaucoma. MPR was performed with MAIA3.

Results: A total of 30 subjects were studied: 40% women, age 58 ± 11 years; T1D duration 31 ± 9 years, mild retinopathy 33%. RS was 27.5 dB (26.1-28.3) and GFS(%) 97.6% (93.5%-99.5%). We found a correlation between RS and memory alteration tests (p = 0.016) and between GFS(%) and a composite of attention and executive neuropsychological tests (p = 0.025). An inverse correlation between GFS and time below range was found. No correlation was found with NfL.

Conclusion: This first exploratory study in people with T1D supports the potential utility of MPR as a screening tool for subclinical neurocognitive alterations in this population.

References

Ciudin A, Ortiz A, Fidilio E, Romero D, Sanchez M, Comas M . Retinal Microperimetry: A Useful Tool for Detecting Insulin Resistance-Related Cognitive Impairment in Morbid Obesity. J Clin Med. 2019; 8(12). PMC: 6947364. DOI: 10.3390/jcm8122181. View

Lacy M, Gilsanz P, Eng C, Beeri M, Karter A, Whitmer R . Severe Hypoglycemia and Cognitive Function in Older Adults With Type 1 Diabetes: The Study of Longevity in Diabetes (SOLID). Diabetes Care. 2019; 43(3):541-548. PMC: 7035586. DOI: 10.2337/dc19-0906. View

Wilkinson C, Ferris 3rd F, Klein R, Lee P, Agardh C, Davis M . Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003; 110(9):1677-82. DOI: 10.1016/S0161-6420(03)00475-5. View

Pena-Casanova J, Blesa R, Aguilar M, Gramunt-Fombuena N, Gomez-Anson B, Oliva R . Spanish Multicenter Normative Studies (NEURONORMA Project): methods and sample characteristics. Arch Clin Neuropsychol. 2009; 24(4):307-19. DOI: 10.1093/arclin/acp027. View

Sachon C, Grimaldi A, Digy J, Pillon B, Dubois B, THERVET F . Cognitive function, insulin-dependent diabetes and hypoglycaemia. J Intern Med. 1992; 231(5):471-5. DOI: 10.1111/j.1365-2796.1992.tb00962.x. View

Clarke W, Cox D, Gonder-Frederick L, Julian D, Schlundt D, Polonsky W . Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995; 18(4):517-22. DOI: 10.2337/diacare.18.4.517. View

Nunley K, Rosano C, Ryan C, Jennings J, Aizenstein H, Zgibor J . Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes. Diabetes Care. 2015; 38(9):1768-76. PMC: 4542271. DOI: 10.2337/dc15-0041. View

Stantonyonge N, Martinez-Horta S, Sampedro F, Sanchez-Saudinos M, Chico A . Defective involuntary attention to novelty in type 1 diabetes and impaired awareness of hypoglycaemia. Diabetes Res Clin Pract. 2021; 177:108898. DOI: 10.1016/j.diabres.2021.108898. View

Sampedro F, Stantonyonge N, Martinez-Horta S, Alcolea D, Lleo A, Munoz L . Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia. BMJ Open Diabetes Res Care. 2020; 8(1). PMC: 7342474. DOI: 10.1136/bmjdrc-2020-001516. View

10.

Perros P, Deary I, Sellar R, Best J, Frier B . Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care. 1997; 20(6):1013-8. DOI: 10.2337/diacare.20.6.1013. View

11.

Stantonyonge N, Sampedro F, Mendez J, Martinez-Horta S, Chico A, Gomez-Anson B . Structural Gray and White Matter Differences in Patients With Type 1 Diabetes and Impaired Awareness of Hypoglycemia. J Clin Endocrinol Metab. 2020; 106(2):450-458. DOI: 10.1210/clinem/dgaa832. View

12.

Dave K, Tamariz J, Desai K, Brand F, Liu A, Saul I . Recurrent hypoglycemia exacerbates cerebral ischemic damage in streptozotocin-induced diabetic rats. Stroke. 2011; 42(5):1404-11. DOI: 10.1161/STROKEAHA.110.594937. View

13.

Battelino T, Danne T, Bergenstal R, Amiel S, Beck R, Biester T . Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019; 42(8):1593-1603. PMC: 6973648. DOI: 10.2337/dci19-0028. View

14.

Cukierman T, Gerstein H, Williamson J . Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies. Diabetologia. 2005; 48(12):2460-9. DOI: 10.1007/s00125-005-0023-4. View

15.

Ciudin A, Simo R . New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes. Front Endocrinol (Lausanne). 2022; 13:1024794. PMC: 9751391. DOI: 10.3389/fendo.2022.1024794. View

16.

Ashton N, Janelidze S, Al Khleifat A, Leuzy A, van der Ende E, Karikari T . A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun. 2021; 12(1):3400. PMC: 8185001. DOI: 10.1038/s41467-021-23620-z. View

17.

Sampedro F, Stantonyonge N, Martinez-Horta S, Nan N, Camacho V, Chico A . Increased cerebral FDG-PET uptake in type 1 diabetes patients with impaired awareness of hypoglycaemia. J Neuroendocrinol. 2020; 33(1):e12910. DOI: 10.1111/jne.12910. View

18.

Rissin D, Kan C, Campbell T, Howes S, Fournier D, Song L . Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol. 2010; 28(6):595-9. PMC: 2919230. DOI: 10.1038/nbt.1641. View

19.

Illan-Gala I, Lleo A, Karydas A, Staffaroni A, Zetterberg H, Sivasankaran R . Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease. Neurology. 2020; 96(5):e671-e683. PMC: 7884995. DOI: 10.1212/WNL.0000000000011226. View

20.

Van Beers C, DeVries J . Continuous Glucose Monitoring: Impact on Hypoglycemia. J Diabetes Sci Technol. 2016; 10(6):1251-1258. PMC: 5094331. DOI: 10.1177/1932296816653411. View